Services: Strategic Drug Development
Our industry experience
can focus on specific areas that are important to assess endpoints that
clearly define go/no-go critera for product progression to include:
• Timelines
and budget estimates;
• Target
profiling;
• Protocol
development;
• Identification
of subcontractors;
• Medical
needs analysis;
• Market
analysis;
• Representation
of plans to investors.
